Major new drug creations keep a close eye on clinical needs

Business Agency March 25 - Major new drug creation technology major special 2015 project declaration work started, focusing on cutting-edge technology, support enterprises to carry out key technologies to help solve the "bottleneck" problem and strategic role of the cultivation of technology research
"The new major new drug creation technology major special project (hereinafter referred to as 'special') than in previous years, more focus on supporting new mechanisms and non-listed drugs innovative varieties of research and development." At the same time, 10 kinds of major diseases, such as malignant tumors, which seriously endangerhealth and, are carried out with innovative drug research of important clinical valueAgainst the subject table, we have several targeted drugs in the research project meet the requirements, will organize the active declaration of personnel"This is the first feeling of Shen Lingjia, deputy general manager of Jiangsu HengruiPharmaceutical, after seeing the relevant noticeHe told reporters, after all, even if there is no state support,enterprisesare doingIf approved, in addition to state funding support, more people look at the recognition at the national levelMarch 19, the National Health and Planning Commission issued a letter to launch the special 2015 project declaration workShen Lingjia read the declaration guide in detail, "the subject focused on the international cutting-edge technology, to support enterprises to carry out key technologies to help solve the 'bottleneck' problem and strategic role of the cultivation of technology research, to encourage innovative thinking more international vision." "
orientation merit
from the variety research and development, the new topic focused on malignant tumors, cardiovascular diseases, neurodegenerative diseases, mental diseases, diabetes, autoimmune diseases, major viral infection diseases and other 10 major diseases to carry out research "National policy focuses on strengthening Shen Lingjia said that as to whether the application can be approved, it will also depend on the results of the follow-up review to carry out international cooperation research on major varieties and core technologies is the focus of this support In 2013, eight of the top 20 global drug companies spent less on research and development In terms of disease, the most popular is the field of cancer and metabolic and endocrine diseases Cooperation and innovation are gradually recognized by pharmaceutical companies at home and abroad As the national major new drug creation special commitment unit, the first sound pharmaceutical industry 7 international cooperation projects, 5 have entered clinical research "This has made our research and development system more open and in line with international standards, and has attracted overseas talent s
eries, establishing an international management system, and thus supporting the productto into the mainstream market," said Yin Xiaojin, vice president of the "
reporters observed that the anti-tumor innovative drug meta-tatinib, jointly developed by Theprior Pharmaceuticals and BMS, has played a role in China's low research and development costs and the rich advantages of clinical trial cases, accelerating the development efficiency of innovative drugs
"The State encourages enterprises to become the main body of innovation, encourages their first input, joint research institutes to carry out research and development, and specially adopts support for projects or post-subsidies." The Guide also places particular emphasis on international cooperation research that is clear about intellectual property rights, risk-sharing and benefit-sharing "Experts believe that this will improve the quality and efficiency of drug research and development in China 2015 will be organized in a "targeted merit"- and "rolling support" and "open merit" Among them, the field of chemical drugs focused on neuropsychiatric diseases (BACE and other targets), metabolic system diseases (PCSK9 and other targets), tumor targeting and immunotherapy (WNT and other targets) new mechanism and new target drug varieties The field of traditional Chinese medicine focuses on supporting the clinical research of innovative Chinese medicine with outstanding clinical advantages The field of biopharmaceuticals supports innovative varieties with better research bases for new structural antibodies, antibody conjugate drugs, new structural proteins and peptide drugs, biosimilars, vaccines, etc The previous the next page the of the 1